Latest filing published 18 Dec 2025 for Galectin Therapeutics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by 10X Fund, L.P. on record concern Galectin Therapeutics Inc. We count 19 filings; the first trade dates from 22 April 2021 and the latest from 2 December 2025.
No open-market purchase appears, only 18 sales worth €888k. So far in 2025, the count stands at no purchases and 4 sales.
The newest entry dates from 18 December 2025: a transaction, in Galectin Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations